Verification of analytical performance of the microalbumin assay on the Abbott Alinity ci®: Experience of the central laboratory Mohammed VI Oujda

Abir Yahyaoui 1, 2, *, Issam Mokhtari 1, 2, Abderazak Saddari 1, 2, Oumayma Hamdani 1, 2, Mouad Harrandou 1, 2, Wissame Azizi 1, 2, Hajar Zrouri 1, 2, Yousra Sbibih 1, 2, El houcine Sebbar 1, 2 and Mohammed Choukri 1, 2

1 Central Laboratory, Mohammed VI University Hospital, Oujda, Morocco.
2 Mohammed First University, Faculty of Medicine and Pharmacy of Oujda, Morocco.
 
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 101–105.
Article DOI: 10.30574/wjbphs.2023.13.3.0123
Publication history: 
Received on 30 January 2023; revised on 10 March 2023; accepted on 13 March 2023
 
Abstract: 
The verification of analytical methods is a requirement of the standard NF EN ISO 15 189. It consists of evaluating the performance of an analytical method according to a well-defined protocol and then comparing it with pre-established analytical objectives. The mastery of this approach must be the concern of any biologist. Through this work we present the results of the protocol of verification of the method of determination of microalbumin by comparing two automats: Alinity ci ® and Architect ci-8200® Abbott. Microalbumin monitoring in urine is an important element in the treatment of diabetes mellitus types I and II. It can also be used to predict diabetic nephropathy, which is the leading cause of death in people with insulin-dependent diabetes.
 
Keywords: 
Microalbumin; Verification; Repeatability; Reproducibility; Alinity ci®; Architect ci8200®
 
Full text article in PDF: 
 
Copyright information: 
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0